City National Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$33.8M Sell
570,363
-10,335
-2% -$656K 0.29% 105
2015
Q2
$38.6M Sell
580,698
-20,741
-3% -$1.37M 0.32% 100
2015
Q1
$38.8M Sell
601,439
-38,583
-6% -$2.42M 0.33% 103
2014
Q4
$37.8M Sell
640,022
-16,061
-2% -$906K 0.33% 104
2014
Q3
$33.6M Sell
656,083
-21,488
-3% -$1.07M 0.31% 111
2014
Q2
$32.9M Sell
677,571
-31,910
-4% -$1.57M 0.3% 110
2014
Q1
$36.9M Sell
709,481
-77,491
-10% -$4.12M 0.52% 77
2013
Q4
$41.8M Sell
786,972
-46,921
-6% -$2.39M 0.63% 44
2013
Q3
$38.6M Sell
833,893
-83,846
-9% -$3.68M 0.68% 40
2013
Q2
$41M Buy
+917,739
New +$39.8M 0.76% 30

Other funds holding BMY

City National Bank's BMY Position: Q3 2015 in Review

City National Bank reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q3 2015, selling an estimated $656K and leaving 570,363 shares worth $33.8M. The position accounts for 0.29% of the portfolio, ranked #105.

City National Bank first reported a position in BMY in Q2 2013 and has held it in 10 quarters since. The position peaked at $41.8M in Q4 2013. 1,453 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

  • City National Bank held 570,363 shares of Bristol-Myers Squibb worth $33.8M as of Q3 2015.
  • City National Bank sold 10,335 Bristol-Myers Squibb shares in Q3 2015, an estimated $656K.
  • Bristol-Myers Squibb made up 0.29% of City National Bank's portfolio in Q3 2015, its #105 holding.
  • City National Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 10 quarters since.
  • City National Bank's Bristol-Myers Squibb position peaked at $41.8M in Q4 2013.
  • 1,453 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.